Once again, DAPT proven to cause more harm than good

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Preprocedural dual antiplatelet therapy (DAPT) before transfemoral transcatheter aortic valve implantation (TF-TAVI) leads to a higher incidence of bleeding with no clinical benefit of reduce thrombotic events compared with either preprocedural single antiplatelet therapy (SAPT) or ...